Corporate News
HC Surgical Raises S$5.0 Million via Convertible Bond (with an Upsize Option to Heliconia) to Fund Business Expansion
- Heliconia to invest S$5.0 million with an option to invest a further S$5.0 million
- HC Surgical intends to use the proceeds for further expansion that align strategically with their
long-term goals
Singapore, 29 July 2019 – Catalist-listed HC Surgical Specialists Limited (SGX:1B1 (“HCSS” or the “Company”) is pleased to announce that it has on 26 July 2019, entered into an investment agreement (“Investment Agreement”) with Heliconia Capital Management Pte. Ltd. (“Heliconia”).
Chief Executive Officer of HCSS, Dr. Heah Sieu Min said, “Our successful business strategy has continued to deliver concrete results and attract reputable investors. With the support from Heliconia, we will be in a stronger position to expand and deliver top quality healthcare services to our patients in Singapore and overseas.”
Mr. Pong Chen Yih, Chief Operating Officer of Novus Corporate Finance Pte. Ltd., the financial adviser to HCSS for the investment, said, “Novus Corporate Finance is pleased to have supported HCSS in this partnership with Heliconia. This strategic investment is particularly significant in solidifying HCSS’s foothold in the market and in its plans to expand and increase shareholders’ value.”
